The Leadership Team at GRAIL is responsible for guiding the company's strategic direction and overseeing its operational execution to develop innovative blood tests for early cancer detection. This diverse group, including executives from various domains such as commercial operations, technology, clinical development, and regulatory affairs, collaborates to ensure that GRAIL's vision is realized effectively, driving advances in cancer diagnostics while fostering a culture of excellence and compliance. They play a critical role in aligning resources, managing partnerships, and advocating for the company's mission both internally and externally.
Aaron Freidin
CFO
Andy Partridge
Chief Commercial Officer
Bob Ragusa
CEO
Gordon Cann
Principal Scientist
Harpal Kumar
President, Biopharma Business ...
Josh Ofman
President
Julie Currie
Chief People Officer
Megan P. Hall
Distinguished Scientist, VP Co...
Paul Ciccolella
SVP, Global Technology and Ope...
Satnam Alag
SVP, Software Engineering & Ch...